There have been over last 20 years many attempts at trying to introduce an androgenic product for women. For numerous reasons there have been no successful registered products available for clinicians despite over 4 million off label prescriptions per annum being written for a testosterone product for women in the USA alone. A recent consensus opinion from the representative clinical colleges outlined the importance of a registered product being made available for women diagnosed with hypoandrogenism. This would then open the door for multiple other uses for androgenic products as a therapeutic intervention in conditions which are being targeted by company such as HavaH Therapeutics.
HavaH Therapeutics is dedicated to developing androgenic products for women and draws on an extensive international network of experts.
After 30 years of preclinical and clinical research into androgen function in women I intend to use this blog to elaborate on how I personally view the developments occurring in the andrology of women.